Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents significant social, economic and political challenges worldwide. SARS-CoV-2 has caused over 3.5 million deaths since late 2019. Mutations in the spike (S) glycoprotein are of particular concern because it harbours...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/14/7425 |
_version_ | 1797527071660965888 |
---|---|
author | Mohd Zulkifli Salleh Jeremy P. Derrick Zakuan Zainy Deris |
author_facet | Mohd Zulkifli Salleh Jeremy P. Derrick Zakuan Zainy Deris |
author_sort | Mohd Zulkifli Salleh |
collection | DOAJ |
description | The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents significant social, economic and political challenges worldwide. SARS-CoV-2 has caused over 3.5 million deaths since late 2019. Mutations in the spike (S) glycoprotein are of particular concern because it harbours the domain which recognises the angiotensin-converting enzyme 2 (ACE2) receptor and is the target for neutralising antibodies. Mutations in the S protein may induce alterations in the surface spike structures, changing the conformational B-cell epitopes and leading to a potential reduction in vaccine efficacy. Here, we summarise how the more important variants of SARS-CoV-2, which include cluster 5, lineages B.1.1.7 (Alpha variant), B.1.351 (Beta), P.1 (B.1.1.28/Gamma), B.1.427/B.1.429 (Epsilon), B.1.526 (Iota) and B.1.617.2 (Delta) confer mutations in their respective spike proteins which enhance viral fitness by improving binding affinity to the ACE2 receptor and lead to an increase in infectivity and transmission. We further discuss how these spike protein mutations provide resistance against immune responses, either acquired naturally or induced by vaccination. This information will be valuable in guiding the development of vaccines and other therapeutics for protection against the ongoing coronavirus disease 2019 (COVID-19) pandemic. |
first_indexed | 2024-03-10T09:37:49Z |
format | Article |
id | doaj.art-fc72b03ef7224c81a893754de52f6de3 |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-10T09:37:49Z |
publishDate | 2021-07-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-fc72b03ef7224c81a893754de52f6de32023-11-22T03:58:22ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-07-012214742510.3390/ijms22147425Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune EvasionMohd Zulkifli Salleh0Jeremy P. Derrick1Zakuan Zainy Deris2Department of Medical Microbiology & Parasitology, School of Medical Sciences, Universiti Sains Malaysia Health Campus, Kubang Kerian 16150, MalaysiaLydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Oxford Road, Manchester M13 9PL, UKDepartment of Medical Microbiology & Parasitology, School of Medical Sciences, Universiti Sains Malaysia Health Campus, Kubang Kerian 16150, MalaysiaThe emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents significant social, economic and political challenges worldwide. SARS-CoV-2 has caused over 3.5 million deaths since late 2019. Mutations in the spike (S) glycoprotein are of particular concern because it harbours the domain which recognises the angiotensin-converting enzyme 2 (ACE2) receptor and is the target for neutralising antibodies. Mutations in the S protein may induce alterations in the surface spike structures, changing the conformational B-cell epitopes and leading to a potential reduction in vaccine efficacy. Here, we summarise how the more important variants of SARS-CoV-2, which include cluster 5, lineages B.1.1.7 (Alpha variant), B.1.351 (Beta), P.1 (B.1.1.28/Gamma), B.1.427/B.1.429 (Epsilon), B.1.526 (Iota) and B.1.617.2 (Delta) confer mutations in their respective spike proteins which enhance viral fitness by improving binding affinity to the ACE2 receptor and lead to an increase in infectivity and transmission. We further discuss how these spike protein mutations provide resistance against immune responses, either acquired naturally or induced by vaccination. This information will be valuable in guiding the development of vaccines and other therapeutics for protection against the ongoing coronavirus disease 2019 (COVID-19) pandemic.https://www.mdpi.com/1422-0067/22/14/7425SARS-CoV-2COVID-19spike variantsspike mutationsimmune evasiontransmission |
spellingShingle | Mohd Zulkifli Salleh Jeremy P. Derrick Zakuan Zainy Deris Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion International Journal of Molecular Sciences SARS-CoV-2 COVID-19 spike variants spike mutations immune evasion transmission |
title | Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion |
title_full | Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion |
title_fullStr | Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion |
title_full_unstemmed | Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion |
title_short | Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion |
title_sort | structural evaluation of the spike glycoprotein variants on sars cov 2 transmission and immune evasion |
topic | SARS-CoV-2 COVID-19 spike variants spike mutations immune evasion transmission |
url | https://www.mdpi.com/1422-0067/22/14/7425 |
work_keys_str_mv | AT mohdzulkiflisalleh structuralevaluationofthespikeglycoproteinvariantsonsarscov2transmissionandimmuneevasion AT jeremypderrick structuralevaluationofthespikeglycoproteinvariantsonsarscov2transmissionandimmuneevasion AT zakuanzainyderis structuralevaluationofthespikeglycoproteinvariantsonsarscov2transmissionandimmuneevasion |